Preview

Pediatric pharmacology

Advanced search

Comprehensive Approach to Developing Baseline Reference Ranges for Platelet Function

https://doi.org/10.15690/pf.v20i2.2530

Abstract

Background. Thrombocytopathies are topical issues of pediatrics. Platelet dysfunction clinically manifests as thrombotic and hemorrhagic events of various severity and location. Platelet function can be evaluated via aggregatometry. Specified parameters for aggregatometry can be used in pediatrics as a standard for evaluating platelet function in peripheral blood. There were no similar studies in children in Russian Federation.

Objective. The aim of the study is — to justify the significance of reference ranges (RR) development for platelet aggregatometry in pediatrics.

Methods. The study included 30 relatively healthy patients aged from 1 to 18 years. Laboratory tests included complete blood count via automatic hematological analyzer; platelet aggregation in whole blood was evaluated via impedance aggregometer; plasmic hemostasis component (Quick prothrombin), activated partial thromboplastin time (APTT), thrombin time (TT), and fibrinogen were evaluated on automatic coagulation analyzer; molecular genetic study of platelet genes polymorphisms was performed via real-time PCR. Several inducers were used to study platelet aggregation: thrombin receptor activating peptide (TRAP), adenosine diphosphate (ADP), arachidonic acid (ASPI). Instrumental methods included electrocardiography, ultrasound of abdomen, urinary system, and thyroid gland.

Results. The study included 16 girls and 14 boys. The median age was 9.4, interquartile range (IQR) was 6.5; 14,1. RR for platelet aggregation indicators were determined for all aggregation inducers (thrombin, ADP, arachidonic acid) as a result of the study.

Conclusion. The obtained data will allow to improve the diagnosis approach for platelet dysfunction regarding the established reference ranges. The results of further research may contribute in the development of the algorithm for controlling antiplatelet therapy in patients with contraindications or with genetically determined low sensitivity to thrombocyte aggregation inhibitors based on acetylsalicylic acid.

About the Authors

Olga B. Gordeeva
Research Institute of Pediatrics and Children’s Health in Petrovsky National Research Centre of Surgery; Pirogov Russian National Research Medical University
Russian Federation

Olga B. Gordeeva, MD, PhD

10, build 1, Fotievoy street, Moscow, 119333


Disclosure of interest:

Not declared.



Maria S. Karaseva
Research Institute of Pediatrics and Children’s Health in Petrovsky National Research Centre of Surgery
Russian Federation

Maria S. Karaseva, MD

Moscow


Disclosure of interest:

Not declared.



Vasily A. Lastovka
Morozovskaya Children’s City Hospital
Russian Federation

Vasiliy A. Lastovka, MD. PhD

Moscow


Disclosure of interest:

Not declared.



Nato D. Vashakmadze
Research Institute of Pediatrics and Children’s Health in Petrovsky National Research Centre of Surgery; Pirogov Russian National Research Medical University
Russian Federation

Nato D. Vashakmadze, MD, PhD, Professor

Moscow


Disclosure of interest:

Not declared.



Margarita A. Soloshenko
Research Institute of Pediatrics and Children’s Health in Petrovsky National Research Centre of Surgery
Russian Federation

Margarita A. Soloshenko, MD, PhD

Moscow


Disclosure of interest:

Not declared.



Gregory V. Revunenkov
Research Institute of Pediatrics and Children’s Health in Petrovsky National Research Centre of Surgery
Russian Federation

Grigory V. Revunenkov, MD, PhD

Moscow


Disclosure of interest:

Not declared.



Kirill A. Valyalov
Research Institute of Pediatrics and Children’s Health in Petrovsky National Research Centre of Surgery
Russian Federation

Kirill A. Valyalov, MD

Moscow


Disclosure of interest:

Not declared.



Viktor V. Altunin
Research Institute of Pediatrics and Children’s Health in Petrovsky National Research Centre of Surgery
Russian Federation

Viktor V. Altunin, MD. PhD

Moscow


Disclosure of interest:

Not declared.



References

1. Mazurov A.V. Fiziologiya i patologiya trombotsitov: Monography. Moscow: Litterra; 2011. 456 p. (In Russ).]

2. Sveshnikova AN, Yakusheva AA, Ryabykh AA, et al. Modern views on the regulation of platelet-dependent hemostasis. Creative Cardiology. 2018;12(3):260–274. (In Russ). doi: https://doi.org/10.24022/1997-3187-2018-12-3-260-274]

3. Vasina LV, Petrishchev NN, Vlasov TD. Markers of endothelial dysfunction. Regional blood circulation and microcirculation. 2017;16(1):4–15. (In Russ). doi: https://doi.org/10.24884/1682-6655-2017-16-1-4-15]

4. Savchenko AP, Medvedev IN. Mekhanizmy funktsionirovaniya trombotsitarnogo gemostaza. Fundamental’nye issledovaniya. 2009;(10):28–30. (In Russ).]

5. Karakhalis NB, Efimochkin GA, Shadrin AK, Sinkov SV. Antithrombotic Therapy in Children. Anesteziologiya I Reanimatologiya = Russian Journal of Anaesthesiology and Reanimatology. 2018;63(1):46–55. (In Russ). doi: http://doi.org/10.18821/0201-7563-2018-63-1-46-55]

6. CLSI. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory: Approved Guideline. 3rd ed. CLSI document C28-A3. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.

7. CLSI. Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays: Approved Guideline, 5th ed. CLSI document H21-A5. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.

8. All Union State Standard Р 15195-2006 “Laboratory medicine. Requirements for reference measurements laboratories”. Date of validity January 01, 2008. (In Russ).] Доступно по: https://docs.cntd.ru/document/1200053110. Ссылка активна на 17.09.2022.

9. All Union State Standard Р 53022.1-2008 “Medical laboratory technologies. Requirements for quality of clinical laboratory tests. Part 4. Rules for development of requirements for timeliness of laboratory information submitting”. Date of validity January 01, 2010. (In Russ).] Доступно по: https://docs.cntd.ru/document/1200069395. Ссылка активна на 17.09.2022.

10. Detskaya gematologiya: Clinical guidelines. Rumyantsev AG, Maschan AA, Zhukovskaya EV, eds. Moscow: GEOTAR-Media; 2015. 656 p. (In Russ).]

11. Ling LQ, Liao J, Niu Q, et al. Evaluation of an automated light transmission aggregometry. Platelets. 2017;28(7):712–719. doi: https://doi.org/10.1080/09537104.2016.1265923

12. Petrova ОV, Shashin SА, Tarasov DG. Reference values of platelet aggregation in impedance aggregometry with adenosine diphosphoric acid on aggregometer multiplate. Sovremennye tehnologii v medicine. 2016;8(3):100–104. (In Russ). doi: http://doi.org/10.17691/stm2016.8.3.11]

13. NCCLS. How to Define and Determine Reference Intervals in the Clinical Laboratory: Approved Guideline. 2nd ed. NCCLS document C28-A2. Wayne, PA: Clinical and Laboratory Standards Institute; 2000.

14. H alimeh S, Angelis G, Sander A, et al. Multiplate® Whole Blood Impedance Point of Care Aggregometry Preliminary Reference Values in Healthy Infants, Children and Adolescents. Klin Padiatr. 2010;222(3):158–163. doi: https://doi.org/10.1055/s-0030-1249081

15. Kovalchuk YuP, Kadinskaya MI, Pimenov MS, Efimova IYu. Determination of reference ranges for automated platelet aggregometry on Sysmex CS-5100 analyzer. Medical alphabet.

16. ;(13):42–46. (In Russ). doi: https://doi.org/10.33667/2078-5631-2021-13-42-46]

17. Platton S, McCormick Á, Bukht M, et al. A multicenter study to evaluate automated platelet aggregometry on Sysmex CS-series coagulation analyzers-preliminary findings. Res Pract Thromb Haemost. 2018;2(4):778–789. doi: https://doi.org/10.1002/rth2.12140

18. Otto NYu, Sagitova GR, Ledyaev MYa, et al. Thrombosis in children (clinical cases). Journal of Volgograd State Medical University. 2020;(2):182–184. (In Russ). doi: https://doi.org/10.19163/1994-9480-2020-2(74)-182-184]

19. Online Mendelian Inheritance in Man (OMIM). In: National Library of Medicine. 15 Sep 2022. Available online https://www.ncbi.nlm.nih.gov/omim. Accessed on September 16, 2022.

20. Mansurova JA, Zhunuspekova AS, Karazhanova LK. Reference values of platelet aggregometry in healthy subjects. Klinicheskaya Laboratornaya Diagnostika = Russian Clinical Laboratory Diagnostics. 2018;63(9):549–552. (In Russ). doi: http://doi.org/10.18821/0869-2084-2018-63-9-549-552]


Review

For citations:


Gordeeva O.B., Karaseva M.S., Lastovka V.A., Vashakmadze N.D., Soloshenko M.A., Revunenkov G.V., Valyalov K.A., Altunin V.V. Comprehensive Approach to Developing Baseline Reference Ranges for Platelet Function. Pediatric pharmacology. 2023;20(2):102–111. (In Russ.) https://doi.org/10.15690/pf.v20i2.2530

Views: 490


ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)